Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Med Stock Analysis Medifast Inc Gains 2.57 At 10.36 In Wellness Sector Uptrend 20260403 Pvla Stock Analysis Palvella Therapeutics Inc. Biotech Update Post 1.58 Dip To 122.69 20260401 Is Newtekone Newtg Stock Undervalued Now Price At 25.15 Down 0.43 20260413 Will Bk Tech Bkti Stock Outperform Peers Price At 79.06 Down 5.68 20260406 Is Psyence Pbm Stock Priced Correctly Price At 2.53 Up 2.43 20260406 Market Wrap Tech outperforms as consumer sector lags in mixed trading session Rafael Holdings RFL Stock Buy or Sell Edges Up 20260418 Southern SOJF Moat Analysis Southern Company 2025A notes post 105 EPS beat Acadia REIT AKR Stock Cancelled Order 216 20260418 UL Unilever Q4 2010 earnings top analyst estimates shares rise modestly despite year over year revenue drop Market Pulse Tech leads consumer shares as indexes drift slightly lower Albemarle Corporation ALB ShortTerm Trading Dip Amid Broader Market Gains Strong Fundamental Outlook Supports Bullish Thesis AX Axos posts 33 percent Q1 2026 EPS beat shares drop 222 percent on cautious investor sentiment RAAQW Real Asset acquisition pipeline in focus as warrants trade near intrinsic value amid merger speculation Is Cohen COHN stock worth taking a position in The critical factors shaping Fifth FITBO future Sideways 20260508 How PennyMac PMTV revenue breaks down and what it means Smart Money Active 20260505 AG 1st Majestic Q4 2025 EPS far outpaces analyst estimates but shares dip 144 percent today Is Pursuit PRSU stock failing at resistance Q4 2025 Earnings Fall Short Honda Abandons AllElectric Goal Signals Hybrid Pivot After Recent Loss JPMorganLed Bank Group Tightens Credit Line to KKR Private Credit Fund as Losses Mount Closing Arguments Conclude in Musk v Altman Advisory Jury Verdict Expected Next Week Centurion ALFUU Stock Consolidating at 1080 Next Move Ahead 20260515 Why NewtekOne NEWTP Just Dropped 061 What to Watch 20260515 Research REFR Stock Analysis Falls 063 Watching 076 20260518 What Ooma OOMAs 093 Jump Means for Investors 20260514 Marcus MMI Q1 2026 Results Fall Short EPS 008 Revenue NA DEE Development Engineers Reports 12 Decline in Q4 Net Profit Revenue Grows Amid Rising Costs Berkshire Hathaway Revamps Portfolio with 26 Billion Delta Stake and Major Alphabet Increase Taiwan Takes Center Stage in TrumpXi Talks Raising Stakes for Global Semiconductor Supply Chains JANX Q1 2026 Earnings Narrowed Loss Beats Estimates Clinical Pipeline Progress Underway Bond Duration Strategy May Shield Portfolios From Interest Rate Hikes China Emerges as Leading Competitor in Humanoid Robotics Race Says Teslas Musk Diversified Energy Strikes Deal to Acquire Maverick Natural Resources in Permian Basin Expansion Deutsche Bank Lifts Equinix Price Target on Data Center Growth Prospects Venture Global VG Highlighted as Potential Multibagger Stock for 2026 CABA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Autoimmune Pipeline CompX International Inc CIX Q1 2026 Earnings EPS of 048 Highlights Operational Stability Amid Quiet Reporting VSECU Q1 2026 Earnings Strong EPS Beat of 2776 Surprise Shares Dip Slightly Caseys General Stores CASY Q1 2026 Earnings EPS Surges Past Estimates Yet Shares Edge Lower Insulet Corporation PODD Q1 2026 Earnings EPS Surges Past Estimates Despite Slight Stock Pullback AN2 Therapeutics ANTX Rallies 5 as Bulls Test Critical Resistance at 540 STSSW Warrants Hold Steady at 004 as Trading Range Narrows Senmiao Technology AIHS Edges Higher in a Tight Range Testing Resistance Near 124 BrilliA Inc BRIA Edges Higher as Shares Test Key Resistance Level State Street SPDR SP Software Services ETF XSW 2026 Investment Profile and RiskReturn Assessment for US Software Sector Exposure How DarkIris DKI compares to the market average Market Focus 20260506 How Amcor AMCR cash flow tells the real story Eye on Rally 20260506 Why FTAI FTAIM deserves a spot in every portfolio Smart Money Exits 20260506 ESLA Estrella Immunopharma falls 392 after Q1 2026 EPS misses analyst forecasts by a wide 906 margin